202 related articles for article (PubMed ID: 26961360)
1. The Elements Steering Pathogenesis in IgG-Mediated Alloimmune Diseases.
Sonneveld ME; van der Schoot CE; Vidarsson G
J Clin Immunol; 2016 May; 36 Suppl 1():76-81. PubMed ID: 26961360
[TBL] [Abstract][Full Text] [Related]
2. The "less-is-more" in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity.
Pereira NA; Chan KF; Lin PC; Song Z
MAbs; 2018 Jul; 10(5):693-711. PubMed ID: 29733746
[TBL] [Abstract][Full Text] [Related]
3. Modulating IgG effector function by Fc glycan engineering.
Li T; DiLillo DJ; Bournazos S; Giddens JP; Ravetch JV; Wang LX
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3485-3490. PubMed ID: 28289219
[TBL] [Abstract][Full Text] [Related]
4. C-Reactive Protein Enhances IgG-Mediated Cellular Destruction Through IgG-Fc Receptors
Temming AR; Tammes Buirs M; Bentlage AEH; Treffers LW; Feringa H; de Taeye SW; Kuijpers TW; Nagelkerke SQ; Brasser G; Mok JY; van Esch WJE; van den Berg TK; Rispens T; van der Schoot CE; Vidarsson G
Front Immunol; 2021; 12():594773. PubMed ID: 33790888
[TBL] [Abstract][Full Text] [Related]
5. A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy.
Kapur R; Kustiawan I; Vestrheim A; Koeleman CA; Visser R; Einarsdottir HK; Porcelijn L; Jackson D; Kumpel B; Deelder AM; Blank D; Skogen B; Killie MK; Michaelsen TE; de Haas M; Rispens T; van der Schoot CE; Wuhrer M; Vidarsson G
Blood; 2014 Jan; 123(4):471-80. PubMed ID: 24243971
[TBL] [Abstract][Full Text] [Related]
6. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T
PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484
[TBL] [Abstract][Full Text] [Related]
7. Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC.
Repp R; Kellner C; Muskulus A; Staudinger M; Nodehi SM; Glorius P; Akramiene D; Dechant M; Fey GH; van Berkel PH; van de Winkel JG; Parren PW; Valerius T; Gramatzki M; Peipp M
J Immunol Methods; 2011 Oct; 373(1-2):67-78. PubMed ID: 21855548
[TBL] [Abstract][Full Text] [Related]
8. FcγR Binding and ADCC Activity of Human IgG Allotypes.
de Taeye SW; Bentlage AEH; Mebius MM; Meesters JI; Lissenberg-Thunnissen S; Falck D; Sénard T; Salehi N; Wuhrer M; Schuurman J; Labrijn AF; Rispens T; Vidarsson G
Front Immunol; 2020; 11():740. PubMed ID: 32435243
[TBL] [Abstract][Full Text] [Related]
9. Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies.
Cheng ZJ; Garvin D; Paguio A; Moravec R; Engel L; Fan F; Surowy T
J Immunol Methods; 2014 Dec; 414():69-81. PubMed ID: 25086226
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fcγ Receptor Profile.
Bruggeman CW; Dekkers G; Bentlage AEH; Treffers LW; Nagelkerke SQ; Lissenberg-Thunnissen S; Koeleman CAM; Wuhrer M; van den Berg TK; Rispens T; Vidarsson G; Kuijpers TW
J Immunol; 2017 Jul; 199(1):204-211. PubMed ID: 28566370
[TBL] [Abstract][Full Text] [Related]
11. FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils.
Treffers LW; van Houdt M; Bruggeman CW; Heineke MH; Zhao XW; van der Heijden J; Nagelkerke SQ; Verkuijlen PJJH; Geissler J; Lissenberg-Thunnissen S; Valerius T; Peipp M; Franke K; van Bruggen R; Kuijpers TW; van Egmond M; Vidarsson G; Matlung HL; van den Berg TK
Front Immunol; 2018; 9():3124. PubMed ID: 30761158
[TBL] [Abstract][Full Text] [Related]
12. Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens.
Wuhrer M; Porcelijn L; Kapur R; Koeleman CA; Deelder A; de Haas M; Vidarsson G
J Proteome Res; 2009 Feb; 8(2):450-6. PubMed ID: 18942870
[TBL] [Abstract][Full Text] [Related]
13. Structural characterization of GASDALIE Fc bound to the activating Fc receptor FcγRIIIa.
Ahmed AA; Keremane SR; Vielmetter J; Bjorkman PJ
J Struct Biol; 2016 Apr; 194(1):78-89. PubMed ID: 26850169
[TBL] [Abstract][Full Text] [Related]
14. Low pH Exposure During Immunoglobulin G Purification Methods Results in Aggregates That Avidly Bind Fcγ Receptors: Implications for Measuring Fc Dependent Antibody Functions.
Lopez E; Scott NE; Wines BD; Hogarth PM; Wheatley AK; Kent SJ; Chung AW
Front Immunol; 2019; 10():2415. PubMed ID: 31681303
[TBL] [Abstract][Full Text] [Related]
15. Cellular surface plasmon resonance-based detection of anti-HPA-1a antibody glycosylation in fetal and neonatal alloimmune thrombocytopenia.
Szittner Z; Bentlage AEH; Temming AR; Schmidt DE; Visser R; Lissenberg-Thunnissen S; Mok JY; van Esch WJE; Sonneveld ME; de Graaf EL; Wuhrer M; Porcelijn L; de Haas M; van der Schoot CE; Vidarsson G
Front Immunol; 2023; 14():1225603. PubMed ID: 37868955
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
[TBL] [Abstract][Full Text] [Related]
17. Fc-galactosylation modulates antibody-dependent cellular cytotoxicity of therapeutic antibodies.
Thomann M; Reckermann K; Reusch D; Prasser J; Tejada ML
Mol Immunol; 2016 May; 73():69-75. PubMed ID: 27058641
[TBL] [Abstract][Full Text] [Related]
18. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose.
Ferrara C; Grau S; Jäger C; Sondermann P; Brünker P; Waldhauer I; Hennig M; Ruf A; Rufer AC; Stihle M; Umaña P; Benz J
Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12669-74. PubMed ID: 21768335
[TBL] [Abstract][Full Text] [Related]
19. Optimal combination of beneficial mutations for improved ADCC effector function of aglycosylated antibodies.
Yoon HW; Jo M; Ko S; Kwon HS; Lim CS; Ko BJ; Lee JC; Jung ST
Mol Immunol; 2019 Oct; 114():62-71. PubMed ID: 31336250
[TBL] [Abstract][Full Text] [Related]
20. A functional spleen contributes to afucosylated IgG in humans.
Wojcik I; Schmidt DE; de Neef LA; Rab MAE; Meek B; de Weerdt O; Wuhrer M; van der Schoot CE; Zwaginga JJ; de Haas M; Falck D; Vidarsson G
Sci Rep; 2021 Dec; 11(1):24045. PubMed ID: 34911982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]